データなし
大摩:予翰森制药“增持”评级 目标价24港元
新浪香港株12:04
高盛:予翰森制药“买入”评级 目标价20.97港元
新浪香港株09:58
Merck (MRK) Stock Moves -1.72%: What You Should Know
Zacks 06:00
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Benzinga03:29
Sector Update: Health Care Stocks Advance in Afternoon Trading
MT Newswires02:49
Sector Update: Health Care
MT Newswires02:34